Amphenol (APH) slides 5.1% amid broad risk-off tape and lingering insider-sale overhang

Amphenol Corporation (APH) is down 5.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears primarily tied to a broad market de-risking move as investors react to escalating geopolitical tensions and a sharp jump in oil prices, which has pressured cyclical and growth-oriented industrial/tech names. Separately, APH has been trading with elevated sensitivity after its late-January results, and recent insider-sale disclosures may have added to short-term caution.

Details:

Markets turned risk-off after weekend developments in the Middle East, pushing crude prices higher and weighing on U.S. equity futures and many industrial/technology-adjacent stocks.

Amphenol’s Jan. 28, 2026 update showed record Q4/FY2025 results and a Q1 2026 outlook that included acquisition-related costs; even with strong growth, investors have recently focused on normalization risks after an outsized run.

In mid-February, public insider-trading paperwork tied to CEO R. Adam Norwitt reflected option-related transactions and share-sale activity, which can sometimes pressure sentiment in the absence of a fresh company-specific catalyst.

Sources:

Amphenol Investor Relations, U.S. SEC, Investopedia

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$APH Insider Trading Activity

$APH insiders have traded $APH stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $APH stock by insiders over the last 6 months:

LUC WALTER (President, HES Division) has made 0 purchases and 2 sales selling 365,118 shares for an estimated $49,163,430.
CRAIG A LAMPO (SR VP & CFO) has made 0 purchases and 2 sales selling 298,076 shares for an estimated $42,697,133.
MICHAEL R. IVAS (VP & Corporate Controller) has made 0 purchases and 2 sales selling 240,000 shares for an estimated $33,762,588.
PETER STRAUB (President, ISS Division) has made 0 purchases and 3 sales selling 220,000 shares for an estimated $28,458,782.
WILLIAM J DOHERTY (President, CS Division) has made 0 purchases and 2 sales selling 160,000 shares for an estimated $22,643,160.
DAVID M SILVERMAN (Senior VP, Human Resources) sold 120,000 shares for an estimated $16,940,472
LANCE E D'AMICO (Sr. VP, Secretary & GenCounsel) sold 120,000 shares for an estimated $16,801,548
ROBERT LIVINGSTON purchased 10,000 shares for an estimated $1,285,080

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$APH Hedge Fund Activity

We have seen 1,008 institutional investors add shares of $APH stock to their portfolio, and 902 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP added 75,964,718 shares (+9435.8%) to their portfolio in Q4 2025, for an estimated $10,265,871,990
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 23,934,785 shares (-74.1%) from their portfolio in Q4 2025, for an estimated $3,234,546,844
JPMORGAN CHASE & CO added 17,391,036 shares (+102.7%) to their portfolio in Q4 2025, for an estimated $2,350,224,605
FMR LLC removed 13,395,833 shares (-13.4%) from their portfolio in Q4 2025, for an estimated $1,810,312,871
JENNISON ASSOCIATES LLC added 7,930,532 shares (+340.8%) to their portfolio in Q4 2025, for an estimated $1,071,732,094
BANK OF NEW YORK MELLON CORP removed 6,290,275 shares (-26.2%) from their portfolio in Q4 2025, for an estimated $850,067,763
PRICE T ROWE ASSOCIATES INC /MD/ removed 6,148,762 shares (-14.0%) from their portfolio in Q4 2025, for an estimated $830,943,696

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$APH Congressional Stock Trading

Members of Congress have traded $APH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $APH stock by members of Congress over the last 6 months:

REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$APH Analyst Ratings

Wall Street analysts have issued reports on $APH in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citigroup issued a "Buy" rating on 01/12/2026
JP Morgan issued a "Overweight" rating on 10/23/2025
UBS issued a "Buy" rating on 10/23/2025
Truist Securities issued a "Buy" rating on 10/23/2025
Goldman Sachs issued a "Buy" rating on 10/23/2025
Baird issued a "Outperform" rating on 10/10/2025
Evercore ISI Group issued a "Outperform" rating on 10/07/2025

To track analyst ratings and price targets for $APH, check out Quiver Quantitative's $APH forecast page.

$APH Price Targets

Multiple analysts have issued price targets for $APH recently. We have seen 10 analysts offer price targets for $APH in the last 6 months, with a median target of $164.0.

Here are some recent targets:

Asiya Merchant from Citigroup set a target price of $180.0 on 01/29/2026
Guy Hardwick from Barclays set a target price of $175.0 on 01/29/2026
Samik Chatterjee from JP Morgan set a target price of $185.0 on 01/27/2026
Joseph Spak from UBS set a target price of $174.0 on 01/14/2026
William Stein from Truist Securities set a target price of $180.0 on 12/19/2025
Mark Delaney from Goldman Sachs set a target price of $154.0 on 10/23/2025
Wamsi Mohan from B of A Securities set a target price of $150.0 on 10/15/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.